Catechol and aldehyde moieties of 3,4-dihydroxyphenylacetaldehyde contribute to tyrosine hydroxylase inhibition and neurotoxicity
- 1 September 2012
- journal article
- Published by Elsevier in Brain Research
- Vol. 1474, 100-109
Abstract
No abstract availableKeywords
Funding Information
- J.A.D. (NIH R01 ES15507)
This publication has 45 references indexed in Scilit:
- Neurodegeneration and Motor Dysfunction in Mice Lacking Cytosolic and Mitochondrial Aldehyde Dehydrogenases: Implications for Parkinson's DiseasePLOS ONE, 2012
- Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metaboliteNeuroToxicology, 2011
- Dopamine release mediated by the dopamine transporter, facts and consequencesJournal of Neurochemistry, 2011
- Oxidation of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopaminergic Metabolite, to a Semiquinone Radical and an ortho-QuinoneJournal of Biological Chemistry, 2011
- Protein Reactivity of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite, Is Dependent on Both the Aldehyde and the CatecholChemical Research in Toxicology, 2009
- Products of Oxidative Stress Inhibit Aldehyde Oxidation and Reduction Pathways in Dopamine Catabolism Yielding Elevated Levels of a Reactive IntermediateChemical Research in Toxicology, 2009
- Deprotection of Arenediazonium Tetrafluoroborate Ethers with BBr3The Journal of Organic Chemistry, 2009
- Dopamine covalently modifies and functionally inactivates parkinNature Medicine, 2005
- Overexpression of the Protein Phosphatase 2A Regulatory Subunit Bγ Promotes Neuronal Differentiation by Activating the MAP Kinase (MAPK) CascadeJournal of Biological Chemistry, 2002
- Conversion of L-tyrosine to 3,4-dihydroxyphenylalanine by cell-free preparations of brain and sympathetically innervated tissuesBiochemical and Biophysical Research Communications, 1964